Landos Biopharma
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Landos Biopharma generated cash of -$20,477,000, which is more than the previous year. Cash used in financing activities reached the amount of $13,567,000 last year. Net change in cash is therefore $909,000.
Cash Flow
| 2018 | -6.89M | -43K | 5M |
|---|---|---|---|
| 2019 | -9.87M | -40.32M | 59.64M |
| 2020 | -22.96M | 14.13M | 1.51M |
| 2021 | -27.06M | -58.70M | 91.60M |
| 2022 | -45.77M | 74.06M | 0 |
| 2023 | -20.47M | 7.77M | 13.56M |
LABP Cash Flow Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 36.64M | 8.30M | 2.41M | 9.80M | 359K | 2.29M |
Operating activities | ||||||
Net income | -21.93M | -39.27M | -38.42M | -30.14M | -13.46M | -6.04M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 44K | 577K | 196K | 137K | 103K | 80K |
Stock-based compensation expense | 971K | 1.97M | 4.11M | 833K | 0 | 0 |
| Deferred income tax benefit | 971K | 1.97M | 4.11M | 833K | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | 0 | 0 | 0 | -153K | 2.09M | 0 |
Inventories | 0 | 0 | 0 | 153K | -2.09M | 0 |
Accounts payable | -2.12M | -9.47M | 4.26M | 6.50M | 415K | 1.00M |
Cash generated by operating activities | -20.47M | -45.77M | -27.06M | -22.96M | -9.87M | -6.89M |
Investing activities | ||||||
Purchases Of Investments | 0 | -3.67M | -174.85M | -21.71M | -40.31M | 0 |
Investments In Property Plant And Equipment | 0 | -7K | -440K | -181K | -158K | -43K |
Acquisitions Net | 0 | 236K | -235K | 88K | 0 | 0 |
Cash generated by investing activities | 7.77M | 74.06M | -58.70M | 14.13M | -40.32M | -43K |
Financing activities | ||||||
Common Stock Issued | 16.56M | 0 | 93M | 1.51M | 51.66M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -3M | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 13.56M | 0 | 91.60M | 1.51M | 59.64M | 5M |
Net Change In Cash | 909K | 28.33M | 5.88M | -7.39M | 9.44M | -1.93M |
Cash at end of period | 37.54M | 36.64M | 8.30M | 2.41M | 9.80M | 359K |
| Data source | Data source | Data source | Data source |